The U.S. Food and Drug Administration (FDA) recently held a Patient Engagement Advisory Committee meeting focused on clinical trial informed ...
On the heels of an unfavourable advisory committee (AdCom) meeting ... The drug will continue to be available for patients ...
Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
The decision follows a September meeting of the agency's Gastrointestinal Drugs Advisory Committee, which agreed that the ...
Early-stage breast cancer patients in the U.S. may soon be able to access another treatment regime based on the result of a Nov. 7 FDA advisory committee for the Prosense cryoablation system by ...
Engage their networks and support the promotion of the program Assess nominations Recommend award recipients to the Minister of Families, Children and Social Development ...
The Albanese Government is ensuring patients get access to life changing medications and treatments as quickly as possible.Due to an unprecedented ...
Hôpital Glengarry Memorial Hospital (HGMH) is excited to announce a new initiative led by its Patient and Family Advisory ...
Sydney woman Jemma Juckes is eagerly awaiting this week’s decision on whether a groundbreaking new cancer drug will be added to the pharmaceutical benefits scheme. Her life depends on it.
The FDA rejected sotagliflozin 5 years ago for the same indication but for the broader population of adults with T1D, due to ...
On Halloween, Lexicon was haunted again as an FDA advisory committee voted 11-3 to reject Zynquista as an accompanying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback